Our results show a statistically significant decrease in TNF-α levels in serum, PBMCs, and neutrophils of COVID-19 ICU patients compared with healthy controls, suggesting an immunomodulatory effect of SARS-CoV-2 on TNF-α production by PBMCs and neutrophils. The gene discussed is TNF; the disease is COVID-19.